Oligomerization Partially Explains the Lowering of Aβ42 in Alzheimer’s Disease Cerebrospinal Fluid

Publisher： Karger

E-ISSN： 1660-2862|6|4|139-147

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.6, Iss.4, 2009-06, pp. : 139-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased Cerebrospinal Fluid Aβ38/Aβ42 Ratio in Alzheimer Disease

By  

Neurodegenerative Diseases, Vol. 2, Iss. 5, 2006-02 ,pp. : 242-245

Karger

Access to resources Recommend Favorite

S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 6, 2010-06 ,pp. : 373-378

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Families with PSEN1 Mutations

By  

Neurodegenerative Diseases, Vol. 8, Iss. 4, 2011-01 ,pp. : 202-207

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Present and the Future

By  

Neurodegenerative Diseases, Vol. 8, Iss. 6, 2011-06 ,pp. : 413-420

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Profile of Amyloid β Peptides in Patients with Alzheimer’s Disease Determined by Protein Biochip Technology

By  

Neurodegenerative Diseases, Vol. 1, Iss. 4-5, 2004-11 ,pp. : 231-235

Karger

Access to resources Recommend Favorite